Related references
Note: Only part of the references are listed.Role of TGF Beta and PPAR Alpha Signaling Pathways in Radiation Response of Locally Exposed Heart: Integrated Global Transcriptomics and Proteomics Analysis
Vikram Subramanian et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy
Ritwik Datta et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment
Aramita Ray et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
TGF-β Signaling from Receptors to Smads
Akiko Hata et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Hsp90/Cdc37 assembly modulates TGFβ receptor-II to act as a profibrotic regulator of TGFβ signaling during cardiac hypertrophy
Ritwik Datta et al.
CELLULAR SIGNALLING (2015)
Getting to the Heart of the Matter New Insights Into Cardiac Fibrosis
Andrew Leask
CIRCULATION RESEARCH (2015)
A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect
Santanu Rana et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ
Jademilson Celestino dos Santos et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
I-TASSER server: new development for protein structure and function predictions
Jianyi Yang et al.
NUCLEIC ACIDS RESEARCH (2015)
An Ideal PPAR Response Element Bound to and Activated by PPARα
John Tzeng et al.
PLOS ONE (2015)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
A map of the PPARα transcription regulatory network for primary human hepatocytes
Patrick D. McMullen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Peroxisome proliferator-activated receptor a activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway
M. Jiao et al.
CELL DEATH & DISEASE (2014)
Arjunolic acid: A new multifunctional therapeutic promise of alternative medicine
Jyotirmoy Ghosh et al.
BIOCHIMIE (2013)
NF-κB mediated miR-26a regulation in cardiac fibrosis
Chuanyu Wei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data
Jing Huang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2013)
Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ
Josefine Stockert et al.
PLOS ONE (2013)
The Novel PPAR α/γ Dual Agonist MHY 966 Modulates UVB-Induced Skin Inflammation by Inhibiting NF-κB Activity
Min Hi Park et al.
PLOS ONE (2013)
Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction
A. Mitra et al.
CELL DEATH & DISEASE (2013)
Therapeutic Potential of Terminalia Arjuna in Cardiovascular Disorders
Subir K. Maulik et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2012)
Improved model quality assessment using ProQ2
Arjun Ray et al.
BMC BIOINFORMATICS (2012)
Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart
Saiful Anam Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna
A. Sai Ramesh et al.
NATURAL PRODUCT RESEARCH (2012)
BSP-SLIM: A blind low-resolution ligand-protein docking approach using predicted protein structures
Hui Sun Lee et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2012)
Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization
Dong Xu et al.
BIOPHYSICAL JOURNAL (2011)
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Esther E. Creemers et al.
CARDIOVASCULAR RESEARCH (2011)
TAK1 lysine 158 is required for TGF-beta-induced TRAF6-mediated Smad-independent IKK/NF-kappa B and JNK/AP-1 activation
Renfang Mao et al.
CELLULAR SIGNALLING (2011)
New Take on the Role of Angiotensin II in Cardiac Hypertrophy and Fibrosis
Mazen Kurdi et al.
HYPERTENSION (2011)
Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ Agonist
Lihua Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Impact of 2′-Hydroxyl Sampling on the Conformational Properties of RNA: Update of the CHARMM All-Atom Additive Force Field for RNA
Elizabeth J. Denning et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Whole Grape Intake Impacts Cardiac Peroxisome Proliferator-Activated Receptor and Nuclear Factor κB Activity and Cytokine Expression in Rats With Diastolic Dysfunction
E. Mitchell Seymour et al.
HYPERTENSION (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated byTerminalia arjuna(Roxb.)
Santosh Kumar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension
Jian Fang et al.
PHYTOMEDICINE (2010)
Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer
Vivek R. Yadav et al.
TOXINS (2010)
Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures
Takuji Oyama et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload
Nadia Hedhli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Cardiac hypertrophy is enhanced in PPARα-/- mice in response to chronic pressure overload
Pascal J. H. Smeets et al.
CARDIOVASCULAR RESEARCH (2008)
HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets
Sjoerd J. De Vries et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Peroxisome proliferator-activated receptors and inflammation: take it to heart
P. J. H. Smeets et al.
ACTA PHYSIOLOGICA (2007)
Terminalia arjuna Wight & Arn. -: A useful drug for cardiovascular disorders
Shridhar Dwivedi
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Agonists of peroxisome proliferators-activated receptors (PPAR) α, β/δ or γ reduce transforming growth factor (TGF)-β-induced proteoglycans' production in chondrocytes
P. E. Poleni et al.
OSTEOARTHRITIS AND CARTILAGE (2007)
PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages
Andreas von Knethen et al.
JOURNAL OF CELL BIOLOGY (2007)
Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway
HK Lee et al.
EXPERIMENTAL DERMATOLOGY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Phytol directly activates peroxisome proliferator-activated receptor α (PPARα) and regulates gene expression involved in lipid metabolism in PPARα-expressing HepG2 hepatocytes
T Goto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
JH Shim et al.
GENES & DEVELOPMENT (2005)
Histone modifications defining active genes persist after transcriptional and mitotic inactivation
A Kouskouti et al.
EMBO JOURNAL (2005)
Myocardial fibrosis and Diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway
T Ogata et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
PPARα activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats
QN Diep et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
The hinge-helix 1 region of peroxisome proliferator-activated receptor γ1 (PPARγ1) mediates interaction with extracellular signal-regulated kinase 5 and PPARγ1 transcriptional activation:: Involvement in flow-induced PPARγ activation in endothelial cells
M Akaike et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
TGF-β1 and angiotensin networking in cardiac remodeling
S Rosenkranz
CARDIOVASCULAR RESEARCH (2004)
Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells
BL Guo et al.
DIABETES (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-β
K Ono et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis
SS Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Arjunolic acid
AA Ajees et al.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE (2002)
Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family
P Cronet et al.
STRUCTURE (2001)
Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators
G Lazennec et al.
MOLECULAR ENDOCRINOLOGY (2000)
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
CG Brilla et al.
CIRCULATION (2000)
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
D Zhang et al.
NATURE MEDICINE (2000)
TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop
K Kishimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CC1(4) in rats
JC Chen et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2000)
Share Paper
